Jane Street’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$193K Buy
25,499
+913
+4% +$6.9K ﹤0.01% 4766
2025
Q1
$136K Sell
24,586
-6,486
-21% -$35.8K ﹤0.01% 5118
2024
Q4
$179K Buy
31,072
+7,896
+34% +$45.4K ﹤0.01% 5147
2024
Q3
$240K Sell
23,176
-5,507
-19% -$57.1K ﹤0.01% 5079
2024
Q2
$372K Buy
28,683
+7,765
+37% +$101K ﹤0.01% 4812
2024
Q1
$365K Sell
20,918
-53,522
-72% -$934K ﹤0.01% 4414
2023
Q4
$700K Sell
74,440
-69,639
-48% -$655K ﹤0.01% 3730
2023
Q3
$1.61M Buy
144,079
+134,360
+1,382% +$1.5M ﹤0.01% 2454
2023
Q2
$208K Sell
9,719
-10,467
-52% -$224K ﹤0.01% 4565
2023
Q1
$816K Buy
+20,186
New +$816K ﹤0.01% 3079
2022
Q4
Hold
0
5681
2022
Q3
Hold
0
5889
2022
Q2
Hold
0
5709
2022
Q1
Sell
-3,157
Closed -$236K 5773
2021
Q4
$236K Buy
+3,157
New +$236K ﹤0.01% 4258
2021
Q3
Sell
-9,060
Closed -$399K 5351
2021
Q2
$399K Buy
+9,060
New +$399K ﹤0.01% 3668
2021
Q1
Sell
-4,753
Closed -$200K 5052
2020
Q4
$200K Sell
4,753
-1,014
-18% -$42.7K ﹤0.01% 3478
2020
Q3
$264K Buy
5,767
+1,632
+39% +$74.7K ﹤0.01% 2983
2020
Q2
$208K Buy
+4,135
New +$208K ﹤0.01% 3385
2020
Q1
Sell
-4,826
Closed -$298K 3537
2019
Q4
$298K Sell
4,826
-1,054
-18% -$65.1K ﹤0.01% 2680
2019
Q3
$353K Buy
5,880
+3,418
+139% +$205K ﹤0.01% 2546
2019
Q2
$208K Buy
+2,462
New +$208K ﹤0.01% 3101
2019
Q1
Sell
-5,364
Closed -$380K 3388
2018
Q4
$380K Buy
+5,364
New +$380K ﹤0.01% 2350
2018
Q3
Hold
0
3563
2018
Q2
Hold
0
3344
2014
Q4
Sell
-5,981
Closed -$237K 1942
2014
Q3
$237K Sell
5,981
-4,870
-45% -$193K ﹤0.01% 1748
2014
Q2
$467K Buy
+10,851
New +$467K 0.01% 1239